UnknownNot Applicable

Noninvasive Chromosomal Screening for Embryo Selection Trial

Canada120 participantsStarted 2020-12-04

Plain-language summary

To determine the diagnostic accuracy of non-invasive preimplantation genetic testing for aneuploidy (NI-PGT-A) for embryo selection.

Who can participate

Age range21 Years – 35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patient undergoing IVF-ICSI at the Olive Fertility Centre * 21 - 35 years old at the time of enrolment * Elective freeze-all cycle * Planning for single embryo transfer Exclusion Criteria: * Undergoing PGT-A, PGT-SR, PGT-M * History of recurrent pregnancy loss * History of recurrent implantation failure * Planning on transfer of more than 1 embryo

What they're measuring

Predictive value of NI-PGT-A results with implantation rate.

Timeframe: 1 year

Predictive value of NI-PGT-A results with on-going pregnancy rate.

Timeframe: 1 year

Predictive value of NI-PGT-A results with miscarriage rate.

Timeframe: 1 year

Trial details

NCT IDNCT04732013

SponsorOlive Fertility Centre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-04

Contact for this trial

Gary Nakhuda, MD

604-816-5534 nicesttrial@olivefertility.com

View on ClinicalTrials.gov More Infertility trials